COLL - Collegium Pharmaceutical, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$58.00
DETAILS
HIGH:
$60.00
LOW:
$56.00
MEDIAN:
$58.00
CONSENSUS:
$58.00
UPSIDE:
70.24%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue | 780.6 | 631.4 | 566.8 | 463.9 | 276.9 | 310.0 | 296.7 | 280.4 | 28.5 | 1.7 | 0 | 0 | 0 |
| Cost of Revenue | 317.3 | 254.1 | 240.6 | 254.4 | 126.3 | 130.2 | 193.7 | 165.7 | 2.6 | 0.2 | 0.2 | 0 | 0 |
| Gross Profit | 463.3 | 377.3 | 326.2 | 209.5 | 150.6 | 179.8 | 103.0 | 114.7 | 25.9 | 1.5 | (0.2) | 0 | 0 |
| Operating Expenses | |||||||||||||
| R&D Expenses | 0 | 0 | 0 | 4.0 | 9.5 | 9.8 | 10.3 | 8.7 | 8.6 | 14.9 | 8.0 | 15.0 | 14.2 |
| SG&A Expenses | 276.2 | 183.0 | 159.2 | 172.2 | 119.0 | 113.8 | 116.4 | 126.8 | 92.8 | 80.6 | 18.9 | 2.7 | 1.9 |
| Other Expenses | 0 | 24.5 | 0 | 0 | 4.6 | 0 | 0 | 0 | 0 | (0.1) | 0 | 0 | 0 |
| Operating Expenses | 276.2 | 207.4 | 159.2 | 176.2 | 133.0 | 123.6 | 126.8 | 135.4 | 101.3 | 95.6 | 26.9 | 17.7 | 16.0 |
| Operating Income | |||||||||||||
| Operating Income | 187.1 | 169.9 | 167.0 | 33.3 | 17.6 | 56.2 | (23.7) | (20.7) | (75.4) | (94.1) | (26.9) | (17.7) | (16.0) |
| Interest Expense | 82.3 | 74.0 | 83.3 | 63.2 | 21.0 | 28.9 | 0.9 | 20.1 | 0 | 0.1 | 0.4 | 0.3 | 0.1 |
| Interest Income | 11.3 | 14.0 | 15.6 | 1.0 | 0.0 | 0.2 | 1.9 | 1.7 | 0.6 | 0 | 0 | 0 | 0 |
| Profitability | |||||||||||||
| EBITDA | 401.0 | 341.7 | 308.3 | 173.3 | 86.6 | 118.0 | (6.3) | 91.9 | (74.3) | (93.4) | (26.6) | (17.5) | (16.0) |
| EBIT | 174.9 | 172.5 | 159.1 | 34.4 | 17.6 | 56.5 | (21.8) | (19.0) | (74.9) | (94.1) | (26.8) | (17.7) | (16.1) |
| Income Before Tax | 92.6 | 98.6 | 75.7 | (28.8) | (3.4) | 27.6 | (22.7) | (39.1) | (74.9) | (94.2) | (27.3) | (17.9) | (16.2) |
| Income Tax Expense | 29.7 | 29.4 | 27.6 | (3.8) | (74.9) | 0.8 | 0 | 0 | 0 | 0.1 | (0.1) | 0 | 0.1 |
| Net Income | 62.9 | 69.2 | 48.2 | (25.0) | 71.5 | 26.8 | (22.7) | (39.1) | (74.9) | (94.2) | (27.3) | (17.9) | (16.2) |
| Per Share Data | |||||||||||||
| EPS (Basic) | 1.98 | 2.14 | 1.60 | -0.74 | 2.05 | 0.78 | -0.24 | -1.19 | -2.47 | -3.88 | -2.01 | -2.40 | -2.17 |
| EPS (Diluted) | 1.73 | 1.86 | 1.29 | -0.74 | 1.86 | 0.76 | -0.24 | -1.19 | -2.47 | -3.88 | -2.01 | -2.40 | -2.17 |
| Shares Outstanding | 31.7 | 32.3 | 33.7 | 33.8 | 34.9 | 34.4 | 33.5 | 32.9 | 30.3 | 24.3 | 13.5 | 7.5 | 7.5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 251.1 | 70.6 | 238.9 | 173.7 | 186.4 | 174.1 | 170.0 | 146.6 | 118.7 | 153.2 |
| Short-Term Investments | 155.4 | 92.2 | 71.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 211.3 | 228.5 | 179.5 | 183.1 | 105.8 | 83.3 | 73.0 | 77.9 | 10.0 | 2.1 |
| Inventory | 40.9 | 35.6 | 32.3 | 46.5 | 17.4 | 15.6 | 9.6 | 7.8 | 1.8 | 1.3 |
| Other Current Assets | 3.2 | 27.7 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 1.0 | 0.5 | 0.3 |
| Total Current Assets | 691.4 | 482.3 | 537.6 | 420.0 | 315.5 | 277.9 | 255.7 | 237.5 | 133.5 | 158.6 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 16.2 | 20.2 | 22.0 | 26.4 | 27.1 | 27.4 | 20.9 | 9.3 | 1.8 | 1.0 |
| Goodwill | 145.9 | 162.3 | 133.9 | 133.7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 669.5 | 891.4 | 421.7 | 567.5 | 268.7 | 335.9 | 29.5 | 44.3 | 0 | 2.1 |
| Long-Term Investments | 1.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 |
| Other Non-Current Assets | 20.2 | 9.4 | 1.9 | 2.6 | 2.6 | 2.7 | 0.2 | 0.2 | 0.2 | 0.3 |
| Total Non-Current Assets | 965.4 | 1,181.3 | 605.7 | 754.1 | 376.5 | 366.0 | 50.6 | 53.7 | 2.1 | 3.4 |
| Total Assets | 1,656.8 | 1,663.6 | 1,143.3 | 1,174.1 | 692.1 | 643.8 | 306.3 | 291.2 | 135.6 | 162.0 |
| Current Liabilities | ||||||||||
| Account Payables | 10.7 | 3.9 | 8.7 | 3.5 | 4.2 | 10.0 | 6.2 | 12.2 | 5.7 | 9.1 |
| Short-Term Debt | 30.4 | 64.6 | 183.3 | 162.5 | 48.4 | 47.5 | 3.8 | 1.6 | 1.5 | 2.7 |
| Deferred Revenue | 0.7 | 0 | 1.0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.9 |
| Other Current Liabilities | 378.7 | 7.6 | 253.9 | 1.5 | 0.9 | 1.4 | 5.7 | 167.7 | 18.2 | 4.3 |
| Total Current Liabilities | 440.0 | 509.5 | 457.9 | 433.7 | 279.6 | 239.5 | 201.8 | 187.5 | 31.5 | 22.9 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 906.0 | 787.9 | 483.8 | 538.5 | 201.6 | 209.6 | 7.7 | 9.9 | 0 | 1.5 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | (4.1) | 121.8 | 0 | 0 | 0 | 0 | 0 | 0.7 | 0 | 0 |
| Total Non-Current Liabilities | 915.1 | 925.2 | 490.0 | 545.6 | 209.6 | 218.4 | 17.1 | 12.2 | 7.2 | 4.2 |
| Total Liabilities | 1,355.2 | 1,434.7 | 947.9 | 979.3 | 489.1 | 457.8 | 218.9 | 199.7 | 31.5 | 27.1 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (101.1) | (164.0) | (233.2) | (281.3) | (256.3) | (333.1) | (359.9) | (337.2) | (298.0) | (223.2) |
| Accumulated Other Comprehensive Income | 0.3 | 0.1 | 0.0 | 0 | 0 | 0 | 0 | 0 | (1.7) | (1.3) |
| Total Stockholders' Equity | 301.7 | 228.8 | 195.4 | 194.8 | 202.9 | 186.0 | 87.4 | 91.6 | 104.1 | 134.9 |
| Total Liabilities & Equity | 1,656.8 | 1,663.6 | 1,143.3 | 1,174.1 | 692.1 | 643.8 | 306.3 | 291.2 | 135.6 | 162.0 |
| Debt Metrics | ||||||||||
| Total Debt | 940.6 | 859.3 | 674.3 | 709.2 | 258.8 | 266.6 | 21.6 | 11.5 | 1.5 | 4.1 |
| Net Debt | 689.5 | 788.7 | 435.3 | 535.5 | 72.3 | 92.5 | (148.4) | (135.1) | (117.2) | (149.1) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 62.9 | 69.2 | 48.2 | (25.0) | 71.5 | 26.8 | (22.7) | (39.1) | (74.9) | (94.2) |
| Depreciation & Amortization | 220.8 | 169.2 | 149.3 | 138.9 | 68.9 | 61.5 | 15.5 | 110.9 | 0.6 | 0.7 |
| Stock-Based Compensation | 41.9 | 32.4 | 27.1 | 22.9 | 24.3 | 21.9 | 16.5 | 13.8 | 7.9 | 5.8 |
| Change in Working Capital | 3.8 | (55.0) | 21.7 | (12.7) | 13.5 | (25.3) | 24.1 | 64.6 | (2.5) | 12.7 |
| Other Non-Cash Items | 25.6 | 16.0 | 30.6 | 8.5 | 3.4 | 9.0 | (5.6) | 19.3 | (0.0) | (0.0) |
| Operating Cash Flow | 329.3 | 205.0 | 274.7 | 124.2 | 103.6 | 93.9 | 27.8 | 169.4 | (67.0) | (75.1) |
| Investing Activities | ||||||||||
| Capital Expenditure | (1.7) | (1.7) | (0.5) | (1.6) | (1.9) | (373.8) | (6.4) | (24.4) | (1.0) | (3.0) |
| Acquisitions | 0 | (267.5) | 0 | (572.1) | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (127.0) | (111.2) | (92.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 65.2 | 92.6 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | (368.2) | 0 | (18.9) | 0 | (2.5) |
| Investing Cash Flow | (63.5) | (287.8) | (70.8) | (573.7) | (1.9) | (373.8) | (6.4) | (24.4) | (1.0) | (3.0) |
| Financing Activities | ||||||||||
| Net Debt Issuance | (70.4) | 7.5 | (65.9) | 442.7 | (50) | 281.4 | 0 | 10.0 | (2.7) | (2.7) |
| Stock Repurchased | (25.1) | (60.0) | (75) | (14.1) | (47.9) | 0 | (0.8) | (0.6) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (24.6) |
| Other Financing Activities | (20.4) | (8.1) | 0.7 | 8.1 | 8.6 | 5.1 | 2.9 | (127.2) | 1.8 | 0.9 |
| Financing Cash Flow | (110.2) | (60.6) | (140.2) | 436.7 | (89.3) | 286.5 | 2.0 | (117.2) | 33.5 | 135.6 |
| Cash Position | ||||||||||
| Net Change in Cash | 155.5 | (143.4) | 63.8 | (12.7) | 12.3 | 6.6 | 23.4 | 27.8 | (34.5) | 57.5 |
| Cash at Beginning | 96.6 | 240.0 | 176.2 | 189.0 | 176.7 | 170.0 | 146.6 | 118.8 | 153.2 | 95.7 |
| Cash at End | 252.2 | 96.6 | 240.0 | 176.2 | 189.0 | 176.7 | 170.0 | 146.6 | 118.7 | 153.2 |
| Free Cash Flow | 327.6 | 203.3 | 274.3 | 122.6 | 101.6 | (279.8) | 21.3 | 145.0 | (68.0) | (78.0) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 780.6 | 631.4 | 566.8 | 463.9 | 276.9 | 310.0 | 296.7 | 280.4 | 28.5 | 1.7 | 0 | 0 | 0 |
| Gross Profit | 463.3 | 377.3 | 326.2 | 209.5 | 150.6 | 179.8 | 103.0 | 114.7 | 25.9 | 1.5 | (0.2) | 0 | 0 |
| Operating Income | 187.1 | 169.9 | 167.0 | 33.3 | 17.6 | 56.2 | (23.7) | (20.7) | (75.4) | (94.1) | (26.9) | (17.7) | (16.0) |
| Net Income | 62.9 | 69.2 | 48.2 | (25.0) | 71.5 | 26.8 | (22.7) | (39.1) | (74.9) | (94.2) | (27.3) | (17.9) | (16.2) |
| EPS (Diluted) | 1.73 | 1.86 | 1.29 | -0.74 | 1.86 | 0.76 | -0.24 | -1.19 | -2.47 | -3.88 | -2.01 | -2.40 | -2.17 |
| Balance Sheet | |||||||||||||
| Cash & Equivalents | 251.1 | 70.6 | 238.9 | 173.7 | 186.4 | 174.1 | 170.0 | 146.6 | 118.7 | 153.2 | |||
| Total Assets | 1,656.8 | 1,663.6 | 1,143.3 | 1,174.1 | 692.1 | 643.8 | 306.3 | 291.2 | 135.6 | 162.0 | |||
| Total Debt | 940.6 | 859.3 | 674.3 | 709.2 | 258.8 | 266.6 | 21.6 | 11.5 | 1.5 | 4.1 | |||
| Stockholders' Equity | 301.7 | 228.8 | 195.4 | 194.8 | 202.9 | 186.0 | 87.4 | 91.6 | 104.1 | 134.9 | |||
| Cash Flow | |||||||||||||
| Operating Cash Flow | 329.3 | 205.0 | 274.7 | 124.2 | 103.6 | 93.9 | 27.8 | 169.4 | (67.0) | (75.1) | |||
| Capital Expenditure | (1.7) | (1.7) | (0.5) | (1.6) | (1.9) | (373.8) | (6.4) | (24.4) | (1.0) | (3.0) | |||
| Free Cash Flow | 327.6 | 203.3 | 274.3 | 122.6 | 101.6 | (279.8) | 21.3 | 145.0 | (68.0) | (78.0) | |||